NEW YORK, Oct. 30 – Genzyme was given the green light from a court in Belgium to acquire rival Pharming NV, currently in receivership, Genzyme said on Tuesday.

Pharming Group, the subsidiary’s parent company, said it plans to appeal the ruling. In September, the company said it opposed an offer from Genzyme because the bid was too low.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.